Newsletter | December 12, 2025

12.12.25 -- STREAM Edition: Biotech Collaboration Strategy With IGI's Cyril Konto, M.D.

SPONSOR

How can production teams work safer and more efficiently without adding complexity?

This on-demand webinar explores the evolving challenges operators face and shares practical ways to improve prep and column changeover workflows. Gain perspectives on ergonomic design, process simplification, and the role of smart automation in reducing risk and supporting consistency across manufacturing. Watch the session to rethink how safety and efficiency can shape stronger, more resilient operations.

The Technology Debate: Single-Use vs. Stainless Steel

Webinar | Thermo Fisher Scientific Bioproduction

In this discussion you will explore the multi-point case for adopting single-use technologies throughout the workflow via an economic, operational, and environmental sustainability lens.

Selecting Container Closure Systems With Confidence: Lyophilization

Webinar | West Pharmaceutical Services, Inc.

Experts take you through the entire selection process for primary packaging components for lyophilization and provide aspects to consider for all relevant attributes.

The Discovery Of Microbes And Implications For Public Health Today

Video | Life Science Leader

Thomas Levenson, MIT professor and author of So Very Small: How Humans Discovered The Microcosmos, Defeated Germs — And May Still Lose The War Against Infectious Disease, discusses how cultural and political forces shape scientific progress and what it means for drug developers, public health officials, and patients everywhere.

Cell Line Development For Multi-Chain Biologics

Webinar | ATUM

Explore the application of a platform in creating CHO cell lines for manufacturing multi-chain biologics, emphasizing the uniformity of the pools generated by this platform in terms of titer and the rapid selection of these pools.

Biotech Collaboration Strategy With IGI's Cyril Konto, M.D.

Video | Life Science Leader

On this week's Business Of Biotech episode, Cyril Konto, M.D., president, executive director, and CEO at Ichnos Glenmark Innovation (IGI) talks about the promise of multi-specific antibodies, funding the company during the 'biotech winter,' closing a $700 million upfront licensing deal with AbbVie, the impact of China's rising biotech sector, and the keys to successful collaboration.

A Study On At-Line Titer Analysis In Biopharmaceutical Applications

Video | RedShiftBio

Explore the integration of a user-friendly protein analyzer into biopharmaceutical workflows. Learn about its precision across multiple molecules and its impact on accelerating process development.